About STL Pharma Private Limited
Data last updated:
STL Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 12 April 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2010PTC201926. Its GSTIN is 27AAOCS1035Q1ZS (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sejal Viral Dave and Viral Jitendra Dave.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Unit No.102 Thakkar Industrial Estate 20 Champsi Bhimji Road Mazagaon, Mumbai, Maharashtra, India – 400010.
As per the financials filed for FY 2024, the company reported a revenue of ₹73.55 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹61.91 Lakh (net margin 0.8%) and EBITDA of ₹1.98 Cr (EBITDA margin 2.7%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 7% over five years.
The company has about 54 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹10.06 Cr and satisfied charges of ₹6.4 Cr on record. Court records list 2 cases involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website stlpharma.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressUnit No.102 Thakkar Industrial Estate 20 Champsi Bhimji Road Mazagaon, Mumbai, Maharashtra, India – 400010
- IndustryHealthcare, Ayurvedic Products & Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of STL Pharma Private Limited
The main business activity of STL Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of STL Pharma Private Limited FY 2024 filings available
STL Pharma Private Limited reported revenue of ₹73.55 Cr (up 3% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of STL Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 3% growth in the latest year. EBITDA rose 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of STL Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.98 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹61.91 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of STL Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of STL Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of STL Pharma Private Limited
STL Pharma Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services, Pharma Retail and Distribution). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Raksh Bio Science Private Limited | •••• | •••• | •••• | •••• | - | Perambur Purasawalkam, Tamil Nadu, India |
| S K Jain Trading Private Limited | •••• | •••• | •••• | •••• | - | Ballabgarh, Haryana, India |
| Dhanwantary Medicare & Research Centre Private Limited | •••• | •••• | •••• | •••• | 94 | Kolkata, West Bengal, India |
| Wello Retail Private Limited | •••• | •••• | •••• | •••• | 13 | Delhi, India |
| S Kant India Private Limited | •••• | •••• | •••• | •••• | - | Mumbai, Maharashtra, India |
| STL Pharma Private Limited this company | •••• | •••• | •••• | •••• | - | Mumbai, Maharashtra, India |
| Venkatasai Agencies Hyd Private Limited | •••• | •••• | •••• | •••• | - | Hyderabad, Telangana, India |
| Nidhi Associates Private Limited | •••• | •••• | •••• | •••• | 16 | New Delhi, Delhi, India |
| Sanat Products Limited | •••• | •••• | •••• | •••• | - | New Delhi, Delhi, India |
| Avn Ayurveda Formulations Private Limited | •••• | •••• | •••• | •••• | 646 | Madurai, Tamil Nadu, India |
| Eskay Herbal Formulations Private Limited | •••• | •••• | •••• | •••• | - | Jalgaon, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below STL Pharma by revenue in the Healthcare industry (Ayurvedic Products and Services, Pharma Retail and Distribution), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Auditor Details of STL Pharma Private Limited
STL Pharma Private Limited is audited by HIREN J. SAPARIA & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| HIREN J. SAPARIA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of STL Pharma Private Limited
STL Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sejal Viral Dave | Director | 24 Jan 2024 | 2 Years 8 Months | Current |
| Viral Jitendra Dave Also directs: Onyx Global Network LLP | Director | 12 Apr 2010 | 16 Years 5 Months | Current |
| Jitendra Venilal Dave | Director | 12 Apr 2010 | 16 Years 5 Months | Current |
Ownership and Shareholding of STL Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of STL Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Oct 2022 | Yes Bank Limited | ₹10 Cr | Open |
| 08 Feb 2021 | Hdfc Bank Limited | ₹5.72 Lakh | Open |
| 30 Sep 2014 | Hdfc Bank Limited | ₹6.4 Cr | Satisfied |
Total charge records: 3 View all charges
Legal Cases of STL Pharma Private Limited
STL Pharma Private Limited has 2 court cases on record: 1 filed against it, 1 where it is another party. All cases are disposed. Status as checked between 03 Oct 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 1 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (SUMMONS CASES SS) | Company is another party | Disposed |
| District court, Thane, Maharashtra | Court case (Other Misc.Cri.Appln) | Filed against the company by State- Food and Drug Narpoli Police Station | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at STL Pharma Private Limited
STL Pharma Private Limited has a workforce of 54 employees as of Mar 23, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on STL Pharma Private Limited
STL Pharma Private Limited has 3 board changes on record since 2010: 3 appointments. The latest: Sejal Viral Dave was appointed as Director on 24 Jan 2024.
Credit Ratings, Litigation & Regulatory Alerts for STL Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by STL Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of STL Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of STL Pharma Private Limited
STL Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAOCS1035Q1ZS | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of STL Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about STL Pharma Private Limited
STL Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 12 April 2010 (16+ years old) and is registered under CIN U24100MH2010PTC201926.
STL Pharma reported revenue of ₹73.55 Cr for FY 2024 (up 3% YoY).
STL Pharma has 3 current directors:
- Sejal Viral Dave - Director
- Viral Jitendra Dave - Director
- Jitendra Venilal Dave - Director
STL Pharma reported a net profit of ₹61.91 Lakh (net margin 0.8%) and EBITDA of ₹1.98 Cr (EBITDA margin 2.7%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of STL Pharma is 12% over three years and 7% over five years. In the latest year (FY 2024) revenue rose 3%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of STL Pharma is 27AAOCS1035Q1ZS, registered in Maharashtra.
The CIN (Corporate Identification Number) of STL Pharma is U24100MH2010PTC201926. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
STL Pharma has 2 court cases on record: 1 filed against it.
STL Pharma was incorporated on 12 April 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of STL Pharma by revenue are Raksh Bio Science Private Limited, S K Jain Trading Private Limited, Dhanwantary Medicare & Research Centre Private Limited, Wello Retail Private Limited, S Kant India Private Limited and 5 more, all in the Healthcare industry (Ayurvedic Products and Services, Pharma Retail and Distribution).
Sejal Viral Dave was appointed as Director on 24 Jan 2024. Jitendra Venilal Dave was appointed as Director on 12 Apr 2010. Viral Jitendra Dave was appointed as Director on 12 Apr 2010.